---
title: "Bajaj Healthcare Ltd (BAJAJHCARE) — Share Price, Financials & Analysis"
symbol: "BAJAJHCARE"
company: "Bajaj Healthcare Ltd"
canonical: "https://tapetide.com/stocks/BAJAJHCARE"
isin: "INE411U01027"
nse_symbol: "BAJAJHCARE"
bse_code: "539872"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 1121.3
generated_at: "2026-09-13T19:41:07.329Z"
---

# Bajaj Healthcare Ltd (BAJAJHCARE)

Canonical page: https://tapetide.com/stocks/BAJAJHCARE

## Company

- **NSE Symbol:** BAJAJHCARE
- **BSE Code:** 539872
- **ISIN:** INE411U01027
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2021-11-25
- **CEO:** Mr. Sajankumar Rameshwarlal Bajaj
- **Employees:** 918
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** bajajhealth.com

## About

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations[1]

## Latest Price

- **Price:** ₹334.05
- **Change:** +2.25 (+0.68%)
- **Open:** ₹332
- **Day High:** ₹338.4
- **Day Low:** ₹325
- **Previous Close:** ₹331.8
- **Volume:** 131431
- **As Of:** 2026-09-11T09:59:56+00:00

## Key Fundamentals

Observed at 2026-09-11T04:42:32.228441Z.

- **Market Cap:** ₹1121.3 Cr
- **Classification:** Microcap
- **P/E (reported):** 63.6
- **P/E (TTM):** 57.99
- **EPS (TTM):** ₹5.76
- **EPS (reported):** ₹10.38
- **Book Value:** ₹158.34
- **Price to Book:** 2.1
- **Dividend Yield:** 0.45%
- **ROE:** 4%
- **ROCE:** 8.34%
- **Debt to Equity:** 0.47
- **Revenue (yearly):** ₹618.2 Cr
- **Net Income:** ₹21.3 Cr
- **EBITDA:** ₹112 Cr
- **52-Week High:** ₹515.9
- **52-Week Low:** ₹272.35
- **RSI (14):** 53.94

## Tapetide Score

- **Score:** 48 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 39.4 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 31.48 | 9% |
| growth | 42.82 | 9% |
| momentum | 30.91 | 12% |
| ownership | 53.31 | 24% |
| quality | 58.27 | 22% |
| valuation | 49.48 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- The company has delivered a poor sales growth of -1.44% over past five years.
- Company has a low return on equity of 3.48% over last 3 years.
- Dividend payout has been low at 12.2% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -8.90%
- Working capital days have increased from 90.8 days to 132 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 168.64% | -37.07% | — |
| ebitda margin growth | 364.86% | -0.06% | 2.78% | 2.9% |
| net income growth | 159.83% | -50.35% | -1% | -13% |
| revenue growth | 6.67% | 10% | -2% | -1% |
| roce | — | -36.72% | 132.96% | 14.27% |
| roe | — | -56.57% | 2.69% | -81.59% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 101 | 109 | 134 | 132 | 133 | 123 | 154 | 149 | 148 | 161 | 153 | 166 |
| Expenses | 82 | 89 | 118 | 108 | 109 | 101 | 143 | 124 | 121 | 131 | 130 | 137 |
| Operating Profit | 19 | 20 | 16 | 24 | 25 | 22 | 12 | 25 | 27 | 31 | 23 | 29 |
| OPM % | 19 | 18 | 12 | 19 | 18 | 18 | 8 | 16 | 18 | 19 | 15 | 17 |
| Other Income | -7 | -7 | -36 | 0 | 4 | -1 | 13 | 1 | 0 | 1 | -34 | 1 |
| Interest | 8 | 7 | 6 | 8 | 8 | 6 | 6 | 5 | 6 | 6 | 6 | 6 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 6 | 7 | 7 | 8 | 7 |
| Profit before tax | -3 | -1 | -33 | 9 | 14 | 8 | 11 | 14 | 15 | 19 | -24 | 16 |
| Tax % | 4 | 58 | -10 | 23 | 30 | -39 | 1 | 17 | 24 | 17 | -6 | 16 |
| Net Profit | -3 | -2 | -30 | 7 | 9 | 12 | 11 | 12 | 11 | 16 | -23 | 14 |
| EPS in Rs | -1.25 | -0.8 | -10.84 | 2.58 | 3 | 3.71 | 3.54 | 3.75 | 3.52 | 4.96 | -6.79 | 4.07 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 327 | 370 | 410 | 657 | 680 | 646 | 473 | 543 | 611 | 628 |
| Expenses | 288 | 327 | 362 | 521 | 561 | 534 | 397 | 460 | 506 | 519 |
| Operating Profit | 39 | 43 | 48 | 136 | 119 | 112 | 76 | 83 | 105 | 109 |
| OPM % | 12 | 12 | 12 | 21 | 17 | 17 | 16 | 15 | 17 | 17 |
| Other Income | 2 | 1 | 7 | 7 | 1 | -19 | -105 | 16 | -32 | -32 |
| Interest | 8 | 8 | 7 | 8 | 13 | 18 | 30 | 28 | 22 | 23 |
| Depreciation | 11 | 11 | 12 | 16 | 18 | 17 | 28 | 28 | 28 | 29 |
| Profit before tax | 23 | 24 | 36 | 119 | 90 | 58 | -86 | 43 | 23 | 25 |
| Tax % | 33 | 33 | 30 | 30 | 20 | 25 | -3 | 7 | 33 | — |
| Net Profit | 15 | 16 | 25 | 83 | 71 | 43 | -84 | 40 | 16 | 18 |
| EPS in Rs | 5.5 | 5.91 | 9.14 | 30.11 | 25.87 | 15.59 | -30.36 | 12.51 | 4.68 | 5.76 |
| Dividend Payout % | 5 | 0 | 0 | 5 | 6 | 6 | -3 | 8 | 32 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7 | 7 | 7 | 14 | 14 | 14 | 14 | 14 | 16 | 17 |
| Reserves | 92 | 107 | 122 | 164 | 245 | 315 | 354 | 265 | 450 | 516 |
| Borrowings | 75 | 87 | 81 | 91 | 181 | 257 | 415 | 333 | 223 | 249 |
| Other Liabilities | 45 | 68 | 57 | 74 | 86 | 136 | 115 | 154 | 144 | 141 |
| Total Liabilities | 219 | 268 | 267 | 343 | 526 | 721 | 898 | 765 | 833 | 923 |
| Fixed Assets | 128 | 127 | 128 | 162 | 208 | 270 | 366 | 253 | 238 | 248 |
| CWIP | 0 | 2 | 1 | 5 | 57 | 52 | 22 | 7 | 3 | 8 |
| Investments | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 91 | 140 | 137 | 170 | 260 | 399 | 510 | 506 | 591 | 667 |
| Total Assets | 219 | 268 | 267 | 343 | 526 | 721 | 898 | 765 | 833 | 923 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 22 | 17 | 25 | 21 | 44 | 1 | -22 | 92 | 22 | 58 |
| Cash from Investing Activity | -8 | -12 | -13 | -28 | -109 | -75 | -93 | -11 | -15 | -48 |
| Cash from Financing Activity | -13 | 2 | -13 | 3 | 75 | 62 | 131 | -97 | -6 | 24 |
| Net Cash Flow | 0 | 7 | 0 | -4 | 10 | -12 | 16 | -16 | 0 | 35 |
| Free Cash Flow | 14 | 5 | 11 | -2 | -70 | -74 | -115 | 73 | 10 | 18 |
| CFO/OP | 88 | 57 | 89 | 62 | 58 | 9 | -10 | 138 | 32 | 53 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 83 | 90 | 77 | 88 | 55 | 99 | 110 | 139 | 169 | 140 |
| Inventory Days | 45 | 57 | 45 | 54 | 94 | 143 | 199 | 206 | 206 | 249 |
| Days Payable | 51 | 74 | 45 | 80 | 67 | 94 | 81 | 128 | 127 | 133 |
| Cash Conversion Cycle | 78 | 73 | 77 | 62 | 82 | 148 | 228 | 217 | 248 | 256 |
| Working Capital Days | -4 | 0 | 12 | 24 | 34 | 40 | 27 | 0 | 141 | 132 |
| ROCE % | 13 | 16 | 16 | 18 | 36 | 20 | 14 | 8 | 11 | 11 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 67.69% | 67.73% | 67.73% | 67.73% | 59.19% | 59.19% | 59.19% | 59.19% | 59.19% | 59.19% | 58.29% | 58.59% |
| FIIs | 0.66% | 0.74% | 0.53% | 0.01% | 1.07% | 1.01% | 1.05% | 1.09% | 1.12% | 1.18% | 1.98% | 2.19% |
| DIIs | 0.44% | 0.48% | 0.44% | 0% | 1.97% | 2.36% | 2.52% | 3.16% | 3% | 2.96% | 2.91% | 1.92% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 18.44% | 19.45% | 19.91% | 20.17% | 25.52% | 26.94% | 26.72% | 26.63% | 26.24% | 26.62% | 28.49% | 29.81% |
| Others | 12.78% | 11.61% | 11.39% | 12.09% | 12.26% | 10.5% | 10.52% | 9.93% | 10.45% | 10.05% | 8.33% | 7.48% |
| No. of Shareholders | 28008 | 29626 | 32712 | 32397 | 31993 | 32672 | 35710 | 35980 | 38574 | 37951 | 37696 | 41310 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 6 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 330.49 | Buy |
| EMA (10) | 330.57 | Buy |
| SMA (20) | 326.42 | Buy |
| EMA (20) | 329.24 | Buy |
| SMA (50) | 333.96 | Buy |
| EMA (50) | 328.71 | Buy |
| SMA (100) | 322.67 | Buy |
| EMA (100) | 331.5 | Buy |
| SMA (200) | 343.9 | Sell |
| EMA (200) | 359.49 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 54.54 | Neutral |
| MACD (12,26,9) | 0.9 | Buy |
| Stochastic (14,3,3) | 71.16 | Neutral |
| ADX (14) | 15.08 | Neutral |
| Williams %R (14) | -27.17 | Neutral |
| ATR (14) | 10.31 | High Volatility |
| ROC (12) | 2.33 | Buy |
| Stoch RSI (14) | 83.43 | Sell |
| UO (7,14,28) | 42.38 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Corporate Action-Record Date For Payment Of Final Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4c05096-1c83-4922-9c44-f3b711e9f644.pdf) |
| 2026-08-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11133dc8-9c35-4745-b523-2e33d81416b2.pdf) |
| 2026-08-29 | [Intimation Of 33Rd Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f119b1f2-3b39-47a9-aabb-d4e6cbe612d4.pdf) |
| 2026-08-29 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c4de34c-2dac-4fe8-a175-2c498c4f74d8.pdf) |
| 2026-08-29 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2889963a-f781-4cc9-89c5-5d62013f9025.pdf) |
| 2026-08-29 | [Shareholders Meeting- Dispatch Of Inland Letters To Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2ace00b-ff95-4b18-8938-1f0c47d371ee.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d5cdf3e-b85d-4d28-8d08-c4e7a698a508.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c0abe51-fe33-463a-be99-094d5ccd91c1.pdf) |
| 2026-08-12 | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66fff4c2-1bdf-42cf-92bd-6cc2ee4abf16.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a60f8e9-5db5-423a-9871-bc1355b74f63.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-07-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc82d87f-d30e-4e76-9648-69802ea6eb80.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c21fde77-5c44-4bed-8ac3-f0862299976d.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-20 | [Results-Financial Results For June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb802222-264a-4cef-883a-bc449c191310.pdf) |
| 2026-05-08 | [Results- Financial Results For 31/03/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e56acf0b-aa39-439d-86b5-fd8de33bd016.pdf) |
| 2026-01-16 | [Results-Financial Results For December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab5c7a75-bc3f-4ffd-8e5c-733cd344a6f7.pdf) |
| 2025-10-17 | [Results-Financial Results For 30/09/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcf53eed-0fb6-4013-a458-298bf758c01e.pdf) |
| 2025-07-28 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99c8497f-1c8d-436d-8063-bc0ebf453558.pdf) |
| 2025-07-28 | [Results- Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c73d027f-647e-47aa-ab2b-e75039e48d69.pdf) |
| 2025-05-26 | [Results- Financial Results For 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e46f1e09-6b4f-42b7-96ae-cd2911c12e9e.pdf) |
| 2025-05-26 | [Results- Financial Results For 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=327401e6-e3a7-4c18-9a0a-9f8ae7d5daf2.pdf) |
| 2025-02-11 | [Results-Financial Results For The Quarter & Nine Months Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb5e4e83-4c3a-4699-a389-38b9212655d1.pdf) |
| 2024-11-14 | [Results For 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=733051c5-e41a-47e3-8132-a9a63e3432b8.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fe05889-e3b6-44f7-b223-81acc576aadb.pdf) |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9fe05889-e3b6-44f7-b223-81acc576aadb.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/144922f2-d226-4b65-9106-f8545e2f6048.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4b2e151d-76b5-4d14-bfc4-6120dbc29588.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6dd99cd7-9a84-45cf-a346-a372e4171faa.pdf) |
| Jun 2022 | [Concall - Jun 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e49f6116-1ba5-470b-97ef-95d055853346.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=694c44ba-0d45-4319-af14-704e8dec00ac.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/694c44ba-0d45-4319-af14-704e8dec00ac.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c403b1d0-c2ff-48a6-8192-2ca1c879d18a.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f9368881-a377-47d5-9990-26af0493f378.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8h - Q3 FY26 results; interim dividend ₹15/share; up to ₹7,000 crore NCDs; PAT ₹712.16 crore. | [Machine Readable Form Of Financial Results For The Period Ended December 31, 2025 8h - Q3 FY26 results; interim dividend ₹15/share; up to ₹7,000 crore NCDs; PAT ₹712.16 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3ce4360e-b6ff-489f-8853-5ca6a092b7a1.pdf) |
| 8 May - Quarter ended 31 March 2026 statement confirms no deviation in preferential issue proceeds. | [Compliances-Statement Of Deviation & Variation 8 May - Quarter ended 31 March 2026 statement confirms no deviation in preferential issue proceeds.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0f09adb0-f480-481b-90d0-71b283f88b91.pdf) |
| 8 May - CARE report for quarter ended March 31, 2026 shows Rs 204.97 crore preferential issue utilization with no deviation. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 8 May - CARE report for quarter ended March 31, 2026 shows Rs 204.97 crore preferential issue utilization with no deviation.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/882dde27-ee56-4ba5-931d-bd2d878f7b72.pdf) |
| 8 May - Board approved FY26 audited results, recommended Rs1.50 final dividend, and appointed internal and cost auditors. | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 8 May - Board approved FY26 audited results, recommended Rs1.50 final dividend, and appointed internal and cost auditors.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/56e572ed-73be-4a49-8f73-db22d11ed8a4.pdf) |
| 8 May - Bajaj Healthcare reported Q4 FY26 results, FY26 revenue up 12.6%, and converted 2,079,409 warrants for ₹527 million. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 8 May - Bajaj Healthcare reported Q4 FY26 results, FY26 revenue up 12.6%, and converted 2,079,409 warrants for ₹527 million.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7b77accf-8435-4a79-8fa9-7e8a76612835.pdf) |
| 7 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88556d71-d72f-4f32-9447-976188ed03b7.pdf) |
| 3 Mar - Torrent Power non-deal roadshow (group and one-on-one) in Mumbai on March 9-10, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Mar - Torrent Power non-deal roadshow (group and one-on-one) in Mumbai on March 9-10, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86592c84-2258-44b1-8e4c-d65dc7582016.pdf) |
| 24 Feb - CRISIL reaffirms AA+/Stable and A1+; Torrent to acquire Nabha Power for ~Rs6,889 crore, closing by June 2026. | [Announcement under Regulation 30 (LODR)-Credit Rating 24 Feb - CRISIL reaffirms AA+/Stable and A1+; Torrent to acquire Nabha Power for ~Rs6,889 crore, closing by June 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d4cb47d8-c881-4cc7-a3c3-e8cdaf2dc645.pdf) |
| 24 Apr - Bajaj Healthcare confirms it is not a Large Corporate; outstanding borrowing was Rs 237.54 crore as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 24 Apr - Bajaj Healthcare confirms it is not a Large Corporate; outstanding borrowing was Rs 237.54 crore as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8f8d3b0a-19cb-4b9b-97d8-1612e3a4d14a.pdf) |
| 23 Feb - Virtual meeting with Axis Mutual Fund scheduled Feb 27, 2026 at 04:00 PM IST. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Feb - Virtual meeting with Axis Mutual Fund scheduled Feb 27, 2026 at 04:00 PM IST.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/748e82e8-4eed-4bd7-8d41-465e72755ab6.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2025-12-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff06e2a7-516a-4bc9-acd3-35f6e4025f3d.pdf) |
| 2022-06-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e49f6116-1ba5-470b-97ef-95d055853346.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93a6b344-bd87-4614-8b37-e9120cfc8e8f.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/487608a7-74b6-4b3c-b5ef-871a7f462444.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/36235800-e93b-4fa9-8750-306136bd26f4.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff59bcad-5f96-4ff5-8352-134dc98e597f.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/334f01bc-8b4d-4213-8f35-05d54151ac00.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0cd44b1d-89d3-4d6f-ae20-2943542fbd9b.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539872/76738539872.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532779/73745532779.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539872/72086539872.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532779/68912532779.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:41:07.329Z.